title: Minnesota's Prescription Monitoring Program: how to identify patients who may be abusing controlled substances.
abstract: The Minnesota Prescription Monitoring Program, which was launched by the Minnesota Board of Pharmacy last year, is collecting data on prescriptionsof controlled substances. Reporting is required from in-state pharmacies and others including physicians who dispense medications as well as from out-of-state pharmacies that ship controlled substances to Minnesota residents. This article describes the program, how it works, and how it can benefit physicians.
authors.affiliation: Minnesota Prescription Monitoring Program, USA.
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Carter
authors.forename: Cody
authors.initials: C
authors.lastname: Wiberg
mesh_terms: D000701:Analgesics, Opioid / Q000506:poisoning; D002423:Cause of Death; D003219:Confidentiality / Q000331:legislation & jurisprudence; D061891:Controlled Substances; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D016365:Liability, Legal; D008910:Minnesota; D063487:Prescription Drug Misuse; D012042:Registries
chemical_list: D000701:Analgesics, Opioid; D061891:Controlled Substances